Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF2R | P11717 | 4/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.51 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.51 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2464373 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL12191970 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL15489111 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL15489112 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL6685329 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL24696627 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL13818478 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL5316339 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL13818477 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 | |
| SCHEMBL13713744 | 1.00 | IGF2R (0.62) | IGF2RGAALGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10908090-B2 | Microarray slides that enhance fluorescent signals via plasmonic interaction | Geddes, Chris (US) | 2021-02-02 | — | — | US | claimed |
| US-20180045644-A1 | MICROARRAY SLIDES THAT ENHANCE FLUORESCENT SIGNALS VIA PLASMONIC INTERACTION | Chris Geddes, Director of the Institute of Fluorescence and Professor of Chemistry and | 2018-02-15 | — | — | US | claimed |
| EP-3268724-A1 | MICROARRAY SLIDES THAT ENHANCE FLUORESCENT SIGNALS VIA PLASMONIC INTERACTION | Plasmonix, Inc. (US) | 2018-01-17 | — | — | EP | claimed |
| WO-2016148951-A1 | MICROARRAY SLIDES THAT ENHANCE FLUORESCENT SIGNALS VIA PLASMONIC INTERACTION | PLASMONIX, INC. (US) | 2016-09-22 | — | — | WO | claimed |
| CN-109071607-B | Vancomycin derivatives, preparation method, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2022-09-27 | — | — | CN | disclosed |
| CN-113943330-A | Sugar-containing structure compound, preparation method, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2022-01-18 | — | — | CN | disclosed |
| US-10961278-B2 | Vancomycin derivative, preparation method, pharmaceutical composition and use thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2021-03-30 | — | — | US | disclosed |
| US-10908090-B2 | Microarray slides that enhance fluorescent signals via plasmonic interaction | Geddes, Chris (US) | 2021-02-02 | — | — | US | disclosed |
| US-20190153036-A1 | VANCOMYCIN DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2019-05-23 | — | — | US | disclosed |
| CN-109071607-A | Vancomycin derivatives, preparation method, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2018-12-21 | — | — | CN | disclosed |
| US-20180045644-A1 | MICROARRAY SLIDES THAT ENHANCE FLUORESCENT SIGNALS VIA PLASMONIC INTERACTION | Chris Geddes, Director of the Institute of Fluorescence and Professor of Chemistry and | 2018-02-15 | — | — | US | disclosed |
| EP-3268724-A1 | MICROARRAY SLIDES THAT ENHANCE FLUORESCENT SIGNALS VIA PLASMONIC INTERACTION | Plasmonix, Inc. (US) | 2018-01-17 | — | — | EP | disclosed |
| CN-107325159-A | One class vancomycin derivatives, its preparation method, pharmaceutical composition and purposes | 中国科学院上海药物研究所 | 2017-11-07 | — | — | CN | disclosed |
| WO-2016148951-A1 | MICROARRAY SLIDES THAT ENHANCE FLUORESCENT SIGNALS VIA PLASMONIC INTERACTION | PLASMONIX, INC. (US) | 2016-09-22 | — | — | WO | disclosed |
| US-20070202014-A1 | Tip for biomolecular reaction | NISSHINBO INDUSTRIES, INC. (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070154945-A1 | Immobilized biomolecule and method of detecting substance capable of interacting with biomolecule | NISSHINBO INDUSTRIES, INC. (JP) | 2007-07-05 | — | — | US | disclosed |
| EP-1783492-A2 | Tip for biomolecular reaction containing an immobilized biomolecule | Nisshinbo Industries, Inc. (JP) | 2007-05-09 | — | — | EP | disclosed |
| EP-1722228-A1 | IMMOBILIZED BIOMOLECULE AND METHOD OF DETECTING SUBSTANCE CAPABLE OF INTERACTING WITH BIOMOLECULE | Nisshinbo Industries, Inc. (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961278-B2 | Vancomycin derivative, preparation method, pharmaceutical composition and use thereof | PEPD, VIP, NRDC | IGF2R 3239/4885GAA 309/4885LGALS8 3482/4885 |
| US-20190153036-A1 | VANCOMYCIN DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | PEPD, VIP, NRDC | IGF2R 3239/4885GAA 309/4885LGALS8 3482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.